Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

27. Mai 2015 05:00 ET | Quelle: Affimed NV

Affimed to Present at the Jefferies 2015 Healthcare Conference -- New York

HEIDELBERG, Germany, May 27, 2015 (GLOBE NEWSWIRE) -- Affimed (Nasdaq:AFMD) today announced that Dr. Adi Hoess, CEO, will present a corporate overview at the Jefferies 2015 Healthcare Conference...
13. Mai 2015 06:03 ET | Quelle: Affimed NV

Affimed Announces First Quarter 2015 Financial Results Conference Call

Heidelberg, Germany, May 13, 2015 (GLOBE NEWSWIRE) -- Affimed N.V. (Nasdaq: AFMD) today announced that on May 21, 2015, the Company will release its financial results for the quarter ended March 31,...
04. Mai 2015 16:08 ET | Quelle: Affimed NV

Affimed N.V. Announces Proposed Public Offering of Common Stock

HEIDELBERG, Germany, May 4, 2015 (GLOBE NEWSWIRE) -- Affimed N.V. (Nasdaq: AFMD), a clinical-stage biopharmaceutical company developing highly targeted cancer immunotherapies, today announced that it...
25. März 2015 07:41 ET | Quelle: Affimed NV

Affimed Announces Financial Results for Fourth Quarter and Year End 2014

HEIDELBERG, Germany, March 25, 2015 (GLOBE NEWSWIRE) -- Affimed N.V. (Nasdaq: AFMD), a clinical-stage biopharmaceutical company developing highly targeted cancer immunotherapies, today reported...

Vorherige Seite